Duncan Williams Reiterates Buy and PT of $80 on Varian Medical

Emily Austin , Benzinga Staff Writer

July 27, 2011 9:15am Comments

Duncan Williams reiterated its Buy rating on Varian Medical (NASDAQ: VAR). At the same time, the rating agency left its price target on the company's stock unchanged at $80. On Tuesday, VAR closed the day at $68.57.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: Duncan Williams Reiteration Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

View the Latest Analytics Ratings

1	QQQ, XLK: This Nasdaq 100 Signal Last Flashed In 1999—What Came Next Was Insane
2	KO: Coke's Sweet Switch: Cane Sugar Beverage, Fairlife Ramp On The Way
3	SPY, QQQ: Federal Reserve Rates 'Justified' Despite Being High...
4	NEM: World's Largest Gold Miner Newmont Reports Q2 Results...
5	HON: Honeywell Lifts Outlook As Transformation Picks Up Speed
6	INTC: Intel Q2 Earnings: Revenue Beat, EPS Miss, Chipmaker...
7	MA, V: Visa Hit By Japan's First-Ever Antitrust A...

1	INTC, NVDA: Intel CEO Says He's 'Making Hard But Necessary Decisions...
2	INTC, AAL: Intel, Deckers Outdoor, Unitedhealth, Dow, And American Airli...
3	ORCL: Larry Ellison Couldn't Afford His Electric Bill Once...
4	Trump, Powell Clash Over $3 Billion Federal Reserve Renov...
5	GS: Top 27 Economists Just Delivered a Brutal Reality Check...
6	INTU: $100 Invested In Intuit 20 Years Ago Would Be Worth...
7	CRH: Here's How Much You Would Have Made Owning...

Market Overview

Tickers

Articles

Keywords

Duncan Williams Reiterates Buy and PT of $80 on Varian Medical

Related Articles (VAR)

Latest Ratings